Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT04878029

Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

This phase I/Ib trial seeks to find out the best dose, possible benefits and/or side effects of cabozantinib in combination with enfortumab vedotin in treating…

United States32 participantsStarted 2021-07-23

Treatment: Cabozantinib S-malate, Enfortumab Vedotin

All recent trials (3 shown)

Active — Not RecruitingPhase 2

NCT03744793

Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer

This phase II trial studies how well pemetrexed and avelumab work in treating patients with MTAP-deficient urothelial cancer that has spread to other places in…

United States18 participantsStarted 2019-04-11

Treatment: Avelumab, Pemetrexed

TerminatedPhase 2

NCT03912818

Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer

This phase II trial studies the side effects of durvalumab and chemotherapy before surgery in treating patients with variant histology bladder cancer. Immunothe…

United States7 participantsStarted 2019-04-10

Treatment: Carboplatin, Cisplatin